Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT03787056
Recruiting
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Not applicable · France · 17 sites
Registry update: 16 Jul 2021
NCT03755739
Recruiting
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Phase 2/3 · China · 1 site
Registry update: 25 Jun 2024
NCT03747133
Recruiting
SABR for Renal Tumors
Not applicable · Canada · 1 site
Registry update: 4 Jun 2026
NCT03288532
Recruiting
Renal Adjuvant MultiPle Arm Randomised Trial
Phase 3 · Spain, France, United Kingdom · 67 sites
Registry update: 7 Sept 2020
Conflicting statuses (not updated in the registry for 74 months)
NCT03592472
Recruiting
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Phase 3 · China, Spain, Italy, South Korea, Poland, United States · 38 sites
Registry update: 13 Apr 2025
NCT06336187
Recruiting
European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study)
Not applicable · Italy · 1 site
Registry update: 10 Apr 2024
NCT03981497
Recruiting
Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms
Not applicable · Italy · 1 site
Registry update: 23 Sept 2026
NCT03452774
Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Not applicable · Puerto Rico, United States · 68 sites
Registry update: 28 Oct 2025
NCT03810651
Recruiting
Pencil Beam Scanning in Patients With Renal Tumors
Early phase 1 · United States · 1 site
Registry update: 15 Apr 2026
NCT03374267
Recruiting
Registry Platform Urologic Cancer
Not applicable · Germany · 1 site
Registry update: 12 Nov 2026
NCT03175224
Recruiting
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 2 · Australia, Canada, Spain, France, United Kingdom, Hungary, Italy, Russia, Singapore, Taiwan, United States · 42 sites
Registry update: 27 Jun 2025
NCT03702309
Recruiting
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Not applicable · Canada · 1 site
Registry update: 25 Sept 2026
NCT02830724
Recruiting
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Phase 1/2 · United States · 1 site
Registry update: 29 Oct 2026
NCT04308330
Recruiting
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Phase 1 · United States · 1 site
Registry update: 15 Apr 2026
NCT03093688
Recruiting
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Phase 1/2 · China · 1 site
Registry update: 2 Jul 2025
NCT03382158
Recruiting
International PPB/DICER1 Registry
Not applicable · United States · 1 site
Registry update: 26 Oct 2026
NCT03221335
Recruiting
EUS-guided RFA for Solid Abdominal Neoplasms
Not applicable · Hong Kong · 1 site
Registry update: 20 Mar 2026
NCT02402244
Recruiting
Project: Every Child for Younger Patients With Cancer
Not applicable · Australia, Canada, New Zealand, Puerto Rico, Saudi Arabia, United States · 279 sites
Registry update: 25 Aug 2026
NCT03804320
Recruiting
Protocol Active Surveillance Small Renal Masses (SRMs)
Not applicable · Italy · 1 site
Registry update: 11 Feb 2020
NCT04792463
Recruiting
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Not applicable · United States · 1 site
Registry update: 16 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.